Active enterohepatic cycling is not required for the choleretic actions of 24-norUrsodeoxycholic acid in mice-Reference-Cited by-同舟云学术

Active enterohepatic cycling is not required for the choleretic actions of 24-norUrsodeoxycholic acid in mice

Published:2023-03-22 Issue:6 Volume:8 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Truong Jennifer K.,Li Jianing,Li Qin,Pachura Kimberly,Rao Anuradha,Gumber Sanjeev,Fuchs Claudia Daniela,Feranchak Andrew P.,Karpen Saul J.^ORCID,Trauner Michael,Dawson Paul A.

Funder

National Institutes of Health

Austrian Science Foundation

National Insitutes of Health

Cystic Fibrosis Foundation

National Institues of Health

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/149360/files/pdf

Reference75 articles.

1. Effect of side-chain shortening on the physiologic properties of bile acids: Hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents

2. New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond

3. 24-norUrsodeoxycholic Acid Is Superior to Ursodeoxycholic Acid in the Treatment of Sclerosing Cholangitis in Mdr2 (Abcb4) Knockout Mice

4. Differential effects of norUDCA and UDCA in obstructive cholestasis in mice

5. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic immaturity and breastmilk bile acid metabolites are central determinants of heightened newborn vulnerability to norovirus diarrhea;Cell Host & Microbe;2024-09

2. Metabolic immaturity of newborns and breast milk bile acid metabolites are the central determinants of heightened neonatal vulnerability to norovirus diarrhea;2024-05-01

3. A novel model to study mechanisms of cholestasis in human cholangiocytes reveals a role for the SIPR2 pathway;Hepatology Communications;2024-02-26

4. Targeting bile salt homeostasis in biliary diseases;Current Opinion in Gastroenterology;2024-01-10